This study was published in Cancer 2009 Mar 1;115(5):1021-7
Study title and authors:
Glucose as a prognostic factor in ovarian carcinoma.
Lamkin DM, Spitz DR, Shahzad MM, Zimmerman B, Lenihan DJ, Degeest K, Lubaroff DM, Shinn EH, Sood AK, Lutgendorf SK.
Department of Psychology, University of Iowa, Iowa City, Iowa 52252, USA.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/19156916
This study tested the hypothesis that higher glucose levels predict shorter survival time and time to recurrence in ovarian cancer patients. 199 patients with ovarian cancer were included in the study.
The study found:
(a) For every increase of 70 mg/dL of blood glucose levels, a patient was 2 times more likely to die of ovarian cancer.
(b) For every increase of 70 mg/dL of blood glucose levels, a patient was 2.32 times more likely to have a recurrence of ovarian cancer.
This study shows that higher blood glucose levels are associated with higher rates of ovarian cancer.
The study found that higher glucose levels were associated with shorter survival times in ovarian cancer patients.
AMAZON UK Life Without Bread: How a Low-Carbohydrate Diet Can Save Your Life
AMAZON USA Life Without Bread: How a Low-Carbohydrate Diet Can Save Your Life